Managing Editor, CEJMed
Agnieszka Ludwig-Gałęzowska
Managing Editor, Medicine
E-mail: aga@versita.com
Responsibilities at Versita:
Strategically plans and manages publishing programs in medicine
Launches new journals and book programs in medicine
Appoints and supervises editors of newly launched journals
Evaluates society journals considered for publication
Builds team of Assistant Editors
Recent publications:
Dansonka-Mieszkowska A, Ludwig AH, Kraszewska E, Kupryjańczyk J:
Geographical variations in TP53 mutational spectrum in ovarian carcinomas,
Ann Hum Genet., Vol.70(Pt.5), (2006), pp. 594-604
Ludwig AH , Kupryjańczyk J:
Does MDR-1 G2677T/A polymorphism really associate with ovarian cancer response to paclitaxel chemotherapy,
Clin Cancer Res., Vol. 12(20 Pt1), (2006), p. 6204
Ludwig AH , Bujko M, Kupryjańczyk J:
CHFR gene is neither mutated nor hypermethylated in ovarian cancer,
Cancer Detection and Prevention, Vol.31(3), (2007), pp. 257-61
Ludwig AH , Murawska M, Panek G, Timorek A, Kupryjańczyk J:
Androgen, progesterone and FSH receptor polymorphisms and ovarian cancer risk,
Endocr Relat Cancer.,Vol. 16(3), (2009), pp.1005-16
Hellwig CT, Ludwig-Gałęzowska AH, Concannon CG, Litchfield DW, Prehn JH, Rehm M:
Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activation,
J. Cell Sci., Vol. 123(Pt 9), (2010), pp.1401-6
Ludwig-Gałęzowska AH , Flanagan L, Rehm M:
Apoptosis repressor with caspase recruitment domain, a multifunctional modulator of cell death,
J Cell Mol Med.,Vol. 15(5), (2011), pp. 1044-53
More about: